ATE25196T1 - Stabilisierung von 1-substituierten imidazolderivaten in talk. - Google Patents

Stabilisierung von 1-substituierten imidazolderivaten in talk.

Info

Publication number
ATE25196T1
ATE25196T1 AT82103685T AT82103685T ATE25196T1 AT E25196 T1 ATE25196 T1 AT E25196T1 AT 82103685 T AT82103685 T AT 82103685T AT 82103685 T AT82103685 T AT 82103685T AT E25196 T1 ATE25196 T1 AT E25196T1
Authority
AT
Austria
Prior art keywords
talk
substitute
stabilization
imidazole derivatives
talc
Prior art date
Application number
AT82103685T
Other languages
English (en)
Inventor
Benjamin Eric Joel
Lee Maryann Ott
Lin Lih-Yang Wang
Original Assignee
Syntex Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Syntex Inc filed Critical Syntex Inc
Application granted granted Critical
Publication of ATE25196T1 publication Critical patent/ATE25196T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/12—Magnesium silicate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
AT82103685T 1981-04-30 1982-04-29 Stabilisierung von 1-substituierten imidazolderivaten in talk. ATE25196T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/259,228 US4382091A (en) 1981-04-30 1981-04-30 Stabilization of 1-substituted imidazole derivatives in talc
EP82103685A EP0064283B1 (de) 1981-04-30 1982-04-29 Stabilisierung von 1-substituierten Imidazolderivaten in Talk

Publications (1)

Publication Number Publication Date
ATE25196T1 true ATE25196T1 (de) 1987-02-15

Family

ID=22984086

Family Applications (1)

Application Number Title Priority Date Filing Date
AT82103685T ATE25196T1 (de) 1981-04-30 1982-04-29 Stabilisierung von 1-substituierten imidazolderivaten in talk.

Country Status (4)

Country Link
US (1) US4382091A (de)
EP (1) EP0064283B1 (de)
AT (1) ATE25196T1 (de)
DE (1) DE3275269D1 (de)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4935410A (en) * 1983-03-31 1990-06-19 Rhone-Poulenc Agrochimie S.A. Fungicidal aluminum tris-alkyl-phosphonate composition
FR2543405B1 (fr) * 1983-03-31 1986-01-03 Rhone Poulenc Agrochimie Composition fongicide a base de tris ethyl phosphonate d'aluminium
JPH0653658B2 (ja) * 1984-12-17 1994-07-20 中外製薬株式会社 安定な錠剤の製造法
KR950010150B1 (ko) * 1986-01-14 1995-09-11 쥬우가이세이야꾸 가부시끼가이샤 니코란딜 함유 주사제의 안정화 방법
KR940000232B1 (ko) * 1986-01-17 1994-01-12 쥬우가이세이야꾸 가부시끼가이샤 니코란딜 제제의 안정화 방법
US6749864B2 (en) 1986-02-13 2004-06-15 Takeda Chemical Industries, Ltd. Stabilized pharmaceutical composition
US5433959A (en) * 1986-02-13 1995-07-18 Takeda Chemical Industries, Ltd. Stabilized pharmaceutical composition
GB2189698A (en) * 1986-04-30 1987-11-04 Haessle Ab Coated omeprazole tablets
LT2508B (lt) * 1986-08-15 1994-02-15 American Cyanamid Co Herbicidine kompozicija
WO1993025238A1 (en) * 1992-06-08 1993-12-23 Schering-Plough Healthcare Products, Inc. Stable imidazole anti-fungal powder compositions
US7407955B2 (en) 2002-08-21 2008-08-05 Boehringer Ingelheim Pharma Gmbh & Co., Kg 8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions
DE102004054054A1 (de) 2004-11-05 2006-05-11 Boehringer Ingelheim Pharma Gmbh & Co. Kg Verfahren zur Herstellung chiraler 8-(3-Amino-piperidin-1-yl)-xanthine
BRPI0711558A2 (pt) 2006-05-04 2011-11-08 Boeringer Ingelheim Internat Gmbh polimorfos
PE20080251A1 (es) 2006-05-04 2008-04-25 Boehringer Ingelheim Int Usos de inhibidores de dpp iv
EP1852108A1 (de) 2006-05-04 2007-11-07 Boehringer Ingelheim Pharma GmbH & Co.KG Zusammensetzungen von DPP-IV-Inhibitoren
NZ600126A (en) * 2007-08-17 2013-12-20 Boehringer Ingelheim Int Purine derivatives for use in the treatment of fap-related diseases
PE20140960A1 (es) 2008-04-03 2014-08-15 Boehringer Ingelheim Int Formulaciones que comprenden un inhibidor de dpp4
PE20100156A1 (es) * 2008-06-03 2010-02-23 Boehringer Ingelheim Int Tratamiento de nafld
BRPI0916997A2 (pt) 2008-08-06 2020-12-15 Boehringer Ingelheim International Gmbh Inibidor de dpp-4 e seu uso
UY32030A (es) 2008-08-06 2010-03-26 Boehringer Ingelheim Int "tratamiento para diabetes en pacientes inapropiados para terapia con metformina"
KR101657960B1 (ko) * 2008-08-15 2016-09-20 베링거 인겔하임 인터내셔날 게엠베하 Ｆａｂ-관련 질환의 치료에 사용하기 위한 푸린 유도체
US20200155558A1 (en) 2018-11-20 2020-05-21 Boehringer Ingelheim International Gmbh Treatment for diabetes in patients with insufficient glycemic control despite therapy with an oral antidiabetic drug
EP2382216A1 (de) 2008-12-23 2011-11-02 Boehringer Ingelheim International GmbH Salzformen einer organischen verbindung
AR074990A1 (es) 2009-01-07 2011-03-02 Boehringer Ingelheim Int Tratamiento de diabetes en pacientes con un control glucemico inadecuado a pesar de la terapia con metformina
EA034869B1 (ru) 2009-11-27 2020-03-31 Бёрингер Ингельхайм Интернациональ Гмбх Лечение генотипированных пациентов с диабетом ингибиторами дпп-4, такими как линаглиптин
MX341025B (es) 2010-05-05 2016-08-04 Boehringer Ingelheim Int Gmbh * Terapia de combinacion.
PH12012502524A1 (en) 2010-06-24 2014-02-10 Boehringer Ingelheim Int Diabetes therapy
US9034883B2 (en) 2010-11-15 2015-05-19 Boehringer Ingelheim International Gmbh Vasoprotective and cardioprotective antidiabetic therapy
EP3517539B1 (de) 2011-07-15 2022-12-14 Boehringer Ingelheim International GmbH Substituiertes dimeres chinazolinderivat, dessen herstellung und dessen verwendung in pharmazeutischen zusammensetzungen zur behandlung von diabetes typ i und ii
US9555001B2 (en) 2012-03-07 2017-01-31 Boehringer Ingelheim International Gmbh Pharmaceutical composition and uses thereof
JP6224084B2 (ja) 2012-05-14 2017-11-01 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 糸球体上皮細胞関連障害及び／又はネフローゼ症候群の治療に用いるｄｐｐ−４阻害薬としてのキサンチン誘導体
US20130303554A1 (en) 2012-05-14 2013-11-14 Boehringer Ingelheim International Gmbh Use of a dpp-4 inhibitor in sirs and/or sepsis
WO2013174767A1 (en) 2012-05-24 2013-11-28 Boehringer Ingelheim International Gmbh A xanthine derivative as dpp -4 inhibitor for use in modifying food intake and regulating food preference
US9526728B2 (en) 2014-02-28 2016-12-27 Boehringer Ingelheim International Gmbh Medical use of a DPP-4 inhibitor
CN109310697A (zh) 2016-06-10 2019-02-05 勃林格殷格翰国际有限公司 利格列汀和二甲双胍的组合

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR906046A (fr) * 1942-11-25 1945-12-20 Ig Farbenindustrie Ag Poudre pour lutter contre les poux de corps et autre vermine
US3133866A (en) * 1959-08-31 1964-05-19 Johnson & Johnson Dusting powder composition containing salts of poly basic phosphoric acids
US3801709A (en) 1970-10-27 1974-04-02 Johnson & Johnson Fragrance retention by chelating agent coated talc
US4055652A (en) * 1975-07-07 1977-10-25 Syntex (U.S.A.) Inc. 1-[β(R-thio)phenethyl]imidazoles and derivatives thereof
US4078071A (en) * 1976-03-08 1978-03-07 Syntex (U.S.A.) Inc. Derivatives of substituted N-alkyl imidazoles
US4185086A (en) 1978-05-04 1980-01-22 Johnson & Johnson Talc compositions
US4277475A (en) * 1979-01-11 1981-07-07 Syntex (U.S.A.) Inc. Contraceptive methods employing 1-substituted imidazole derivatives

Also Published As

Publication number Publication date
EP0064283A2 (de) 1982-11-10
US4382091A (en) 1983-05-03
DE3275269D1 (en) 1987-03-05
EP0064283B1 (de) 1987-01-28
EP0064283A3 (en) 1983-07-20

Similar Documents

Publication Publication Date Title
DE3275269D1 (en) Stabilization of 1-substituted imidazole derivatives in talc
DE3682711D1 (de) Als fungizide verwendbare heterocyclische verbindungen.
DK102382A (da) Substituerede 1-aryl-2-azolyl-ethen-derivater og syreadditionssalte,kvaternaere azoliumsalte og metalkomplekser deraf samt deres fremstilling og anvendelse som mikrobicider
BG28026A3 (bg) Фунгицидно средство
GB1236735A (en) Fungicidal agents and methods
ES460595A1 (es) Un procedimiento para preparar acidos 7-beta-(2-oxiimi- no-2-arilacetamido)-3-sulfoalquiltetrazol-5-iltiometil)-3- cefem-4-carboxilicos.
AU517358B2 (en) Fungicidal complexes of metal salts with imidazoles
AU571077B2 (en) Fungicidal naphthylalkylamines
ES8609273A1 (es) Un procedimiento para preparar nuevos derivados de ciano-2- bencimidazol
ES8501607A1 (es) Procedimiento para la obtencion de heterociclos nitrogenosos de 5 miembros
ES341415A1 (es) Procedimiento para preparar derivados de (2,3-b) (1,5) benzotiacepina.
ES8504434A1 (es) Procedimiento para preparar una composicion fungicida a base de una sal de acido alquil-fosforoso
ATE13173T1 (de) Stabilisierte duengerloesungen.
ES8703432A1 (es) Procedimiento para la obtencion de derivados de amida heterociclicos
HU177751B (en) Fungicide compositions containing 1-cycloalkylcarbonyl-3-bracket-3,5-dihalogen-phenyl-bracket closed-imidasolidine-2,4-dione derivatives and process for producing the active agents
ATE17943T1 (de) Als schaedlingsbekaempfungsmittel wirksame pyrimidin derivate.
GB1058535A (en) 7-(-a,-ß-unsaturated acylamino)cephalosporanic acid and derivatives thereof
GB1249268A (en) Carboxamides and compositions containing the same
ZA939604B (en) Imidazole derivatives
ES8400397A1 (es) Un procedimiento para la preparacion de un nuevo peptido activo.
GB1294053A (en) Phosphoric acid esters and their use as insecticides, acaricides and nematocides
AR246737A1 (es) Complejos fungicidas imidazolicos
GB1340888A (en) Pesticidal phosphorus-containing dihydrouracils
ES380220A1 (es) Procedimiento para la obtencion de un medio insecticida, a-caricida y fungicida a base de derivados del acido fosfori- co.
GB1271926A (en) 0h-1,5-benzodiazepinecarboxamide antiinflammatory agents

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EELA Cancelled due to lapse of time